Firmenbeschreibung
Vertex Pharmaceuticals Inc. ist ein globales Biotech-Unternehmen, das sich der Entdeckung und Entwicklung kleinmolekularer Arzneimittel zur Behandlung von schweren Erkrankungen verschrieben hat. Die Strategie des Unternehmens besteht aus der Vermarktung seiner Produkte sowohl unabhängig als auch gemeinsam mit führenden Pharmakonzernen. Die Produktpipeline von Vertex ist hauptsächlich auf Virusinfektionen, Entzündungen, Autoimmunkrankheiten und Krebs ausgerichtet. Vertex vermarktet den HIV-Proteasehemmer Lexiva gemeinsam mit GlaxoSmithKline.
KeyData
| endOfFinancialYear: | 31.12.2024 01:00 |
| stockholderStructure: | Capital World Investors (11.03%),Vanguard Group Inc (9.06%),Blackrock Inc. (8.5%),State Street Corporation (4.67%),Capital Research Global Investors (4.06%),FMR, LLC (3.59%),JP Morgan Chase & Company (2.46%),Wellington Management Group, LLP (2.3%),Geode Capital Management, LLC (2.2%),Jennison Associates LLC (1.68%) |
| sharesOutstanding: | 256789869.0000 |
| ceo: | Reshma Kewalramani, M.D. |
| board: | Charles F. Wagner, Jr., David Altshuler, Stuart A. Arbuckle, Jonathan Biller, Carmen Bozic, Amit K. Sachdev, Bastiano Sanna, Nia Tatsis, E. Morrey Atkinson, Ph.D. |
| supervisoryBoard: | Dr. Jeffrey Leiden, Bruce I. Sachs, Diana McKenzie, Dr. Alan Garber, Dr. Sangeeta N. Bhatia, Lloyd Carney, Reshma Kewalramani, Terrence C. Kearney, Suketu (Suky) Upadhyay |
| countryID: | 20 |
| freeFloat: | 82.7000 |
| faceValue: | 0.0100 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | USA |
| countryName: | USA |
Kontakt
| name: | Susie Lisa |
| phone: | +1-617-341-6108 |
| email: | investorinfo@vrtx.com |
| irWebSite: | https://investors.vrtx.com/ |
Adresse
| street: | 50 Northern Avenue |
| city: | Boston, Massachusetts 02210, USA |
| phone: | +1-617-961-7163 |
| webSite: | www.vrtx.com/ |
| email: | Investorinfo@VRTX.com |
| webcastsWebSite: | https://investors.vrtx.com/events-presentations |
Finanzen (kurz)
| year: | 2022 | cash: | 10504.0000 |
| balanceSheetTotal: | 18150.9000 | liabilities: | 4238.2000 |
| shareCapital: | 2.6000 | totalShareholdersEquity: | 13912.7000 |
| sales: | 8930.7000 | incomeBeforeTaxes: | 4232.4000 |
| netIncome: | 3322.0000 | cashFlow: | 3711.9000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2023 | cash: | 10369.1000 |
| balanceSheetTotal: | 22730.2000 | liabilities: | 5149.8000 |
| shareCapital: | 2.6000 | totalShareholdersEquity: | 17580.4000 |
| sales: | 9869.2000 | incomeBeforeTaxes: | 4379.8000 |
| netIncome: | 3619.6000 | cashFlow: | -139.7000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
| year: | 2024 | cash: | 4569.6000 |
| balanceSheetTotal: | 22533.2000 | liabilities: | 6123.6000 |
| shareCapital: | 2.6000 | totalShareholdersEquity: | 16409.6000 |
| sales: | 11020.1000 | incomeBeforeTaxes: | 248.5000 |
| netIncome: | -535.6000 | cashFlow: | -5800.1000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2022 |
| cash: | 10504.0000 |
| balanceSheetTotal: | 18150.9000 |
| liabilities: | 4238.2000 |
| shareCapital: | 2.6000 |
| totalShareholdersEquity: | 13912.7000 |
| sales: | 8930.7000 |
| incomeBeforeTaxes: | 4232.4000 |
| netIncome: | 3322.0000 |
| cashFlow: | 3711.9000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 10369.1000 |
| balanceSheetTotal: | 22730.2000 |
| liabilities: | 5149.8000 |
| shareCapital: | 2.6000 |
| totalShareholdersEquity: | 17580.4000 |
| sales: | 9869.2000 |
| incomeBeforeTaxes: | 4379.8000 |
| netIncome: | 3619.6000 |
| cashFlow: | -139.7000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2024 |
| cash: | 4569.6000 |
| balanceSheetTotal: | 22533.2000 |
| liabilities: | 6123.6000 |
| shareCapital: | 2.6000 |
| totalShareholdersEquity: | 16409.6000 |
| sales: | 11020.1000 |
| incomeBeforeTaxes: | 248.5000 |
| netIncome: | -535.6000 |
| cashFlow: | -5800.1000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 22730.2000 | cash: | 10369.1000 |
| currentAssets: | 14144.2000 | fixedAssets: | 8586.0000 |
| liabilities: | 3547.4000 | totalLiabilitiesEquity: | 22730.2000 |
| totalShareholdersEquity: | 17580.4000 | property: | 1159.3000 |
| intangibleAssets: | 839.9000 | longTermInvestments: | 2497.8000 |
| inventories: | 738.8000 | accountsReceivable: | 1563.4000 |
| accountsPayable: | 364.9000 | liabilitiesTotal: | 5149.8000 |
| longTermDebt: | 376.1000 | commonStock: | 2.6000 |
| preferredStock: | 0.0000 | sales: | 9869.2000 |
| depreciation: | 181.3000 | netIncome: | 3619.6000 |
| operatingResult: | 3832.0000 | incomeInterest: | 44.1000 |
| investments: | 3162.9000 | incomeTaxes: | 760.2000 |
| costGoodsSold: | 1262.2000 | grossProfit: | 8607.0000 |
| cashFlow: | 3537.3000 | cashFlowInvesting: | -3141.7000 |
| cashFlowFinancing: | -562.2000 | cashFlowTotal: | -139.7000 |
| accountingStandard: | US GAAP | equityRatio: | 77.3438 |
| debtEquityRatio: | 0.0214 | liquidityI: | 2.9230 |
| liquidityII: | 3.3637 | netMargin: | 36.6757 |
| grossMargin: | 87.2107 | cashFlowMargin: | 35.8418 |
| ebitMargin: | 38.8279 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 24.9130 | preTaxROA: | 19.2686 |
| roe: | 20.5888 | roa: | 15.9242 |
| netIncomeGrowth: | 8.9585 | revenuesGrowth: | 10.5087 |
| taxExpenseRate: | 17.3570 | equityTurnover: | 0.5614 |
| epsBasic: | 14.0500 | epsDiluted: | 13.8900 |
| epsBasicGrowth: | 8.3269 | shareCapital: | 2.6000 |
| incomeBeforeTaxes: | 4379.8000 | priceEarningsRatioCompany: | 28.9601 |
| priceCashFlowRatio: | 29.7127 | bookValuePerShare: | 68.0599 |
| marketCap: | 105102867252.2400 | earningsYield: | 3.4530 |
| pegRatio: | 3.4779 | cashFlowPerShare: | 13.6941 |
| priceBookValueRatio: | 5.9784 | priceEarningsRatio: | 29.0371 |
| netEarningsPerShare: | 14.0127 | currency: | USD |
| year: | 2024 | units: | 1000000 |
| balanceSheetTotal: | 22533.2000 | cash: | 4569.6000 |
| currentAssets: | 9596.4000 | fixedAssets: | 12936.8000 |
| liabilities: | 3564.6000 | totalLiabilitiesEquity: | 22533.2000 |
| totalShareholdersEquity: | 16409.6000 | property: | 1227.8000 |
| intangibleAssets: | 825.9000 | longTermInvestments: | 5107.9000 |
| inventories: | 1205.4000 | accountsReceivable: | 1609.4000 |
| accountsPayable: | 413.0000 | liabilitiesTotal: | 6123.6000 |
| longTermDebt: | 112.8000 | commonStock: | 2.6000 |
| preferredStock: | 0.0000 | sales: | 11020.1000 |
| depreciation: | 207.2000 | netIncome: | -535.6000 |
| operatingResult: | -232.9000 | investments: | 3630.3000 |
| incomeTaxes: | 784.1000 | costGoodsSold: | 1530.5000 |
| grossProfit: | 9489.6000 | cashFlow: | -492.6000 |
| cashFlowInvesting: | -3770.0000 | cashFlowFinancing: | -1494.9000 |
| cashFlowTotal: | -5800.1000 | accountingStandard: | US GAAP |
| equityRatio: | 72.8241 | debtEquityRatio: | 0.0069 |
| liquidityI: | 1.2819 | liquidityII: | 1.7334 |
| netMargin: | -4.8602 | grossMargin: | 86.1117 |
| cashFlowMargin: | -4.4700 | ebitMargin: | -2.1134 |
| ebitdaMargin: | 0.0000 | preTaxROE: | 1.5144 |
| preTaxROA: | 1.1028 | roe: | -3.2639 |
| roa: | -2.3769 | netIncomeGrowth: | -114.7972 |
| revenuesGrowth: | 11.6615 | taxExpenseRate: | 315.5332 |
| equityTurnover: | 0.6716 | epsBasic: | -2.0800 |
| epsDiluted: | -2.0800 | epsBasicGrowth: | -114.8043 |
| shareCapital: | 2.6000 | incomeBeforeTaxes: | 248.5000 |
| priceCashFlowRatio: | -209.9255 | bookValuePerShare: | 63.9028 |
| marketCap: | 103409280246.3000 | earningsYield: | -0.5165 |
| cashFlowPerShare: | -1.9183 | priceBookValueRatio: | 6.3018 |
| netEarningsPerShare: | -2.0858 | currency: | USD |
| year: | 2025 | priceCashFlowRatio: | -254.9653 |
| bookValuePerShare: | 63.9028 | marketCap: | 125595924927.9000 |
| earningsYield: | -0.4253 | pegRatio: | 2.0482 |
| cashFlowPerShare: | -1.9183 | netAssetsPerShare: | 63.9028 |
| priceBookValueRatio: | 7.6538 | netEarningsPerShare: | -2.0858 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 22730.2000 |
| cash: | 10369.1000 |
| currentAssets: | 14144.2000 |
| fixedAssets: | 8586.0000 |
| liabilities: | 3547.4000 |
| totalLiabilitiesEquity: | 22730.2000 |
| totalShareholdersEquity: | 17580.4000 |
| property: | 1159.3000 |
| intangibleAssets: | 839.9000 |
| longTermInvestments: | 2497.8000 |
| inventories: | 738.8000 |
| accountsReceivable: | 1563.4000 |
| accountsPayable: | 364.9000 |
| liabilitiesTotal: | 5149.8000 |
| longTermDebt: | 376.1000 |
| commonStock: | 2.6000 |
| preferredStock: | 0.0000 |
| sales: | 9869.2000 |
| depreciation: | 181.3000 |
| netIncome: | 3619.6000 |
| operatingResult: | 3832.0000 |
| incomeInterest: | 44.1000 |
| investments: | 3162.9000 |
| incomeTaxes: | 760.2000 |
| costGoodsSold: | 1262.2000 |
| grossProfit: | 8607.0000 |
| cashFlow: | 3537.3000 |
| cashFlowInvesting: | -3141.7000 |
| cashFlowFinancing: | -562.2000 |
| cashFlowTotal: | -139.7000 |
| accountingStandard: | US GAAP |
| equityRatio: | 77.3438 |
| debtEquityRatio: | 0.0214 |
| liquidityI: | 2.9230 |
| liquidityII: | 3.3637 |
| netMargin: | 36.6757 |
| grossMargin: | 87.2107 |
| cashFlowMargin: | 35.8418 |
| ebitMargin: | 38.8279 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 24.9130 |
| preTaxROA: | 19.2686 |
| roe: | 20.5888 |
| roa: | 15.9242 |
| netIncomeGrowth: | 8.9585 |
| revenuesGrowth: | 10.5087 |
| taxExpenseRate: | 17.3570 |
| equityTurnover: | 0.5614 |
| epsBasic: | 14.0500 |
| epsDiluted: | 13.8900 |
| epsBasicGrowth: | 8.3269 |
| shareCapital: | 2.6000 |
| incomeBeforeTaxes: | 4379.8000 |
| priceEarningsRatioCompany: | 28.9601 |
| priceCashFlowRatio: | 29.7127 |
| bookValuePerShare: | 68.0599 |
| marketCap: | 105102867252.2400 |
| earningsYield: | 3.4530 |
| pegRatio: | 3.4779 |
| cashFlowPerShare: | 13.6941 |
| priceBookValueRatio: | 5.9784 |
| priceEarningsRatio: | 29.0371 |
| netEarningsPerShare: | 14.0127 |
| currency: | USD |
| year: | 2024 |
| units: | 1000000 |
| balanceSheetTotal: | 22533.2000 |
| cash: | 4569.6000 |
| currentAssets: | 9596.4000 |
| fixedAssets: | 12936.8000 |
| liabilities: | 3564.6000 |
| totalLiabilitiesEquity: | 22533.2000 |
| totalShareholdersEquity: | 16409.6000 |
| property: | 1227.8000 |
| intangibleAssets: | 825.9000 |
| longTermInvestments: | 5107.9000 |
| inventories: | 1205.4000 |
| accountsReceivable: | 1609.4000 |
| accountsPayable: | 413.0000 |
| liabilitiesTotal: | 6123.6000 |
| longTermDebt: | 112.8000 |
| commonStock: | 2.6000 |
| preferredStock: | 0.0000 |
| sales: | 11020.1000 |
| depreciation: | 207.2000 |
| netIncome: | -535.6000 |
| operatingResult: | -232.9000 |
| investments: | 3630.3000 |
| incomeTaxes: | 784.1000 |
| costGoodsSold: | 1530.5000 |
| grossProfit: | 9489.6000 |
| cashFlow: | -492.6000 |
| cashFlowInvesting: | -3770.0000 |
| cashFlowFinancing: | -1494.9000 |
| cashFlowTotal: | -5800.1000 |
| accountingStandard: | US GAAP |
| equityRatio: | 72.8241 |
| debtEquityRatio: | 0.0069 |
| liquidityI: | 1.2819 |
| liquidityII: | 1.7334 |
| netMargin: | -4.8602 |
| grossMargin: | 86.1117 |
| cashFlowMargin: | -4.4700 |
| ebitMargin: | -2.1134 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 1.5144 |
| preTaxROA: | 1.1028 |
| roe: | -3.2639 |
| roa: | -2.3769 |
| netIncomeGrowth: | -114.7972 |
| revenuesGrowth: | 11.6615 |
| taxExpenseRate: | 315.5332 |
| equityTurnover: | 0.6716 |
| epsBasic: | -2.0800 |
| epsDiluted: | -2.0800 |
| epsBasicGrowth: | -114.8043 |
| shareCapital: | 2.6000 |
| incomeBeforeTaxes: | 248.5000 |
| priceCashFlowRatio: | -209.9255 |
| bookValuePerShare: | 63.9028 |
| marketCap: | 103409280246.3000 |
| earningsYield: | -0.5165 |
| cashFlowPerShare: | -1.9183 |
| priceBookValueRatio: | 6.3018 |
| netEarningsPerShare: | -2.0858 |
| currency: | USD |
| year: | 2025 |
| priceCashFlowRatio: | -254.9653 |
| bookValuePerShare: | 63.9028 |
| marketCap: | 125595924927.9000 |
| earningsYield: | -0.4253 |
| pegRatio: | 2.0482 |
| cashFlowPerShare: | -1.9183 |
| netAssetsPerShare: | 63.9028 |
| priceBookValueRatio: | 7.6538 |
| netEarningsPerShare: | -2.0858 |
| currency: | USD |
